![]() Akero Therapeutics Akero Therapeutics develops medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. | ![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | ||
Founding Date | Founding Date 2017 | Founding Date 2016 | Founding Date 1992 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations San Francisco, US HQ Cambridge, US South San Francisco, US | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB | Locations Schaumburg, US HQ Gurugram, IN Monthey, CH |
Employees | Employees 1363% increase | Employees 156% decrease | Employees 1152% increase |
Funding | |||
Total funding raised | Total funding raised $ 135m | Total funding raised $ 17m | Total funding raised N/A |

Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View companyIHMA is a company that provides antimicrobial drug development support services.
View company